0000899243-21-010804.txt : 20210309
0000899243-21-010804.hdr.sgml : 20210309
20210309214528
ACCESSION NUMBER: 0000899243-21-010804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210305
FILED AS OF DATE: 20210309
DATE AS OF CHANGE: 20210309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JEFFS ROGER
CENTRAL INDEX KEY: 0001231615
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 21728075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-05
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001231615
JEFFS ROGER
C/O AXSOME THERAPEUTICS, INC
22 CORTLANDT STREET, 16TH FLOOR
NEW YORK
NY
10007
1
0
0
0
Stock Option (Right to Buy)
65.02
2021-03-05
4
A
0
1463
0.00
A
2021-03-05
2031-03-04
Common Stock
1463
1463
D
Represents 1,463 options elected to be received in lieu of cash compensation earned in 2020. All of such options are immediately exercisable.
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
2021-03-09